Management of Substance use Disorder in Military Services: A Comprehensive Approach

Sharbafchi, Mohammad Reza; Heydari, Mostafa

Management of Substance use Disorder in Military Services: A Comprehensive Approach

Document Type : Original Article

Authors

¹ Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² Behavioral Sciences Research Center, Baqiyatallah University of Medical Sciences, Baqiyatallah Hospital, Tehran, Iran

Abstract

Background: Historically, substance misuse has been a serious problem faced by worldwide military personnel. Some research showed that military personnel have higher rates of unhealthy substance use than their age peers in the general population. These problems have serious consequences and may lead to significant military difficulties in the field of readiness, discipline, and mental or physical health. In this review, we gathered various methods for prevention, diagnosis, and treatment of substance use disorders and suggested a comprehensive plan for Iran Armed Forces to improve existing services. Materials and Methods: This article is a narrative review study, which was carried out on 2016. A careful literature review was performed between January 1970 and April 2016 on several national and international databases. Articles were screened according to the following inclusion criteria: (1) review articles about prevention and treatment protocols, (2) executive guidance, (3) cohort articles about risk factors of addiction, and (4) randomized controlled trials about prevention or treatment of substance use disorders in army service members. After screening by title and abstract, 130 articles selected of 832 founded articles, and after quality assessment, finally, 63 articles included in the review. Results: There is a necessity to manage substance use disorder through prevention, screening, and then referral to proper services for diagnosis and treatment. Urinalysis programs for screening are cost-effective and should be considered as a main method. Effective treatment includes both behavioral and pharmacological methods. Conclusions: The ideal prevention program will include multiple and mutually reinforcing evidence-based universal, selective, and indicated attempts at both the individual and environmental levels. The implementation of screening and treatment strategies needs strict rules and national guideline for the comprehensive management of substance use disorders in army.

Keywords

References

1.	Bray RM, Pemberton MR, Lane ME, Hourani LL, Mattiko MJ, Babeu LA. Substance use and mental health trends among U.S. Military active duty personnel: Key findings from the 2008 DoD Health Behavior Survey. Mil Med 2010;175:390-9.
2.	Adams RS, Corrigan JD, Larson MJ. Alcohol use after combat-acquired traumatic brain injury: What we know and don't know. J Soc Work Pract Addict 2012;12:28-51.
3.	Jones E, Fear NT. Alcohol use and misuse within the military: A review. Int Rev Psychiatry 2011;23:166-72.
4.	Larson MJ, Wooten NR, Adams RS, Merrick EL. Military combat deployments and substance use: Review and future directions. J Soc Work Pract Addict 2012;12:6-27.
5.	Wilk JE, Bliese PD, Kim PY, Thomas JL, McGurk D, Hoge CW. Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war. Drug Alcohol Depend 2010;108:115-21.
6.	Jacobson IG, Ryan MA, Hooper TI, Smith TC, Amoroso PJ, Boyko EJ, et al. Alcohol use and alcohol-related problems before and after military combat deployment. JAMA 2008;300:663-75.
7.	Thomas JL, Wilk JE, Riviere LA, McGurk D, Castro CA, Hoge CW. Prevalence of mental health problems and functional impairment among active component and National Guard Soldiers 3 and 12 months following combat in Iraq. Arch Gen Psychiatry 2010;67:614-23.
8.	Bray RM, Olmsted KR, Williams J. Misuse of prescription pain medications in US active duty service members. Pain Syndromes – From Recruitment to Returning Troops: Wounds of War IV. Amsterdam, Netherlands: IOS Press Amsterdam; 2012. p. 3-16.
9.	Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008;9:444-59.
10.	Heydari M, Isfeedvajani MS. Zolpidem dependence, abuse and withdrawal: A case report. J Res Med Sci 2013;18:1006-7.
11.	Eric C, Strain MD, James C, Anthony MS. Introduction and overview. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9^th ed. New York, Philadelphia, PA: Lippincott Williams and Wilkins; 2009. p. 1237-68.
12.	Armed Forces Health Surveillance Center. Absolute and relative morbidity burdens attributable to various illnesses and injuries, US Armed Forces, 2011. MSMR 2012;19:4-9.
13.	Mousavi SG, Sharbafchi MR, Salehi M, Peykanpour M, Karimian Sichani N, Maracy M. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: A double-blind controlled, crossover study. Arch Iran Med 2015;18:28-33.
14.	Salehi M, Emadossadat A, Kheirabadi GR, Maracy MR, Sharbafchi MR. The effect of buprenorphine on methamphetamine cravings. J Clin Psychopharmacol 2015;35:724-7.
15.	Armed Forces Health Surveillance Center. Surveillance snapshot: Recurrent medical encounters associated with alcohol abuse-related diagnostic codes, active component, U.S. Armed Forces, 2001-2010. MSMR 2012;19:23.
16.	Bray RM, Pemberton MR, Hourani LL, Witt M, Olmsted KL, Brown JM, et al. Department of Defense Survey of Health Related Behaviors Among Active Duty Military Personne. Research Triangle Park, NC: RTI International; 2009. Available from: http://www.tricare.mil/2008HealthBehaviors.pdf. [Last cited on 2016 Jun 11].
17.	IOM (Institute of Medicine). Substance Use Disorders in the US Armed Forces. Washington, DC: National Academies Press; 2013.
18.	United Nations Office on Drugs Crime. World Drug Report 2013. Vienna: United Nations Office on Drugs and Crime; 2013.
19.	Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J 2006;3:12.
20.	Barry CL, Huskamp HA. Moving beyond parity – Mental health and addiction care under the ACA. N Engl J Med 2011;365:973-5.
21.	DoD. Comprehensive plan on prevention, diagnosis, and treatment of substance use disorders and disposition of substance use offenders in the armed forces. Washington, DC: Office of the Under Secretary of Defense; 2011.
22.	US Army. Army 2020: Generating Health and Discipline in the Force Ahead of the Strategic Reset. Washington, DC: Department of the Army; 2012.
23.	The Management of Substance Use Disorders Working Group. VA/DOD Clinical Practice Guideline for Management of Sub-stance Use Disorders. (Version 2.1). Washington, DC, Department of Veterans Affairs and the Department of Defense; 2009. Available from: http://www.healthquality.va.gov/Substance_Use_DisorderSUD.asp. [Last cited on 2016 Jul 15].
24.	National Institute for Health and Care Excellence. The Guidelines Manual. NICE; 2009.
25.	Lowinson JH. Substance Abuse: A Comprehensive Textbook. Philadelphia, PA: Lippincott Williams and Wilkins; 2005.
26.	Robertson EB, David SL, Rao SA. Preventing Drug Use Among Children and Adolescents: A Research-based Guide for Parents, Educators, and Community Leaders. 2^nd ed. Rockville, MD: National Institute on Drug Abuse; 2003.
27.	Brody GH, Chen YF, Beach SR, Philibert RA, Kogan SM. Participation in a family-centered prevention program decreases genetic risk for adolescents' risky behaviors. Pediatrics 2009;124:911-7.
28.	Mehrazmay A, Karambakhsh A, Salesi M, Heydari M, Ahmadi K. Predictors of Change in substance abuse status in soldiers. Iran Red Crescent Med J 2015;17:e16305.
29.	Trickett PK, Noll JG, Putnam FW. The impact of sexual abuse on female development: Lessons from a multigenerational, longitudinal research study. Dev Psychopathol 2011;23:453-76.
30.	Foran HM, Smith Slep AM, Heyman RE. Hazardous alcohol use among active duty Air Force personnel: Identifying unique risk and promotive factors. Psychol Addict Behav 2011;25:28-40.
31.	Jakupcak M, Tull MT, McDermott MJ, Kaysen D, Hunt S, Simpson T. PTSD symptom clusters in relationship to alcohol misuse among Iraq and Afghanistan war veterans seeking post-deployment VA health care. Addict Behav 2010;35:840-3.
32.	Seal KH, Metzler TJ, Gima KS, Bertenthal D, Maguen S, Marmar CR. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health 2009;99:1651-8.
33.	Sirratt D, Ozanian A, Traenkner B. Epidemiology and prevention of substance use disorders in the military. Mil Med 2012;177 8 Suppl:21-8.
34.	Blume AW, Marlatt GA. The role of executive cognitive functions in changing substance use: What we know and what we need to know. Ann Behav Med 2009;37:117-25.
35.	Rutter M. Implications of resilience concepts for scientific understanding. Ann N Y Acad Sci 2006;1094:1-12.
36.	ONDCP. National Drug Control Strategy, 2011. Washington, DC: ONDCP; 2011.
37.	National Defense Authorization Act (NDAA). Section 596 “Comprehensive Plan on Prevention, Diagnosis, and Treatment of Substance Use Disorders and Disposition of Substance Abuse Offenders in the Armed Forces”; 2010.
38.	Conduct Problems Prevention Research Group. The implementation of the Fast Track Program: An example of a large-scale prevention science efficacy trial. J Abnorm Child Psychol 2002;30:1-17.
39.	Screening for Mental Health, Inc., Military Mental Health Screening Program; 2012. Available from: http://www.militarymentalhealth.org. [Last cited on 2016 Aug 03].
40.	Ahmadi H, Green SL. Screening, brief intervention, and referral to treatment for military spouses experiencing alcohol and substance use disorders: A literature review. J Clin Psychol Med Settings 2011;18:129-36.
41.	Aschengrau A, Seage GR. Essentials of Epidemiology in Public Health. 2^nd ed. Sudbury, MA: Jones and Bartlett Publishers; 2008.
42.	Fisun AI, Kuvshinov KÉ, Shamrei VK, Alekseev VV, Goncharenko AI, Pastushenkov AV, et al. Prophylaxis of substance abuse in the Armed Forces: Organization and performance of screening. Problem of substance dependence disorders is the actual for many countries in the world and affects on health of servicemen. Voen Med Zh 2014;335:4-12.
43.	Gray BT. A factor analytic study of the Substance Abuse Subtle Screening Inventory (SASSI). Educ Psychol Meas 2001;61:102-18.
44.	Gray JA. New concepts in screening. Br J Gen Pract 2004;54:292-8.
45.	Babor TF, Kadden RM. Screening and interventions for alcohol and drug problems in medical settings: What works? J Trauma 2005;59 3 Suppl:S80-7.
46.	American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 5^th ed. Washington DC, American Psychiatric Pub.; 2013.
47.	Eric C, Strain MD, James C, Anthony MS. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9^th ed. New York: Lippincott Williams and Wilkins; 2009.
48.	Kheirabadi GR, Ghavami M, Maracy MR, Salehi M, Sharbafchi MR. Effect of add-on valproate on craving in methamphetamine depended patients: A randomized trial. Adv Biomed Res 2016;5:149. [PUBMED] [Full text]
49.	McLellan AT, Skipper GS, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. Br Med J 2008;337:1154-6.
50.	McCarty D, McConnell KJ, Schmidt LA. Priorities for policy research on treatments for alcohol and drug use disorders. J Subst Abuse Treat 2010;39:87-95.
51.	Miller WR, Sorensen JL, Selzer JA, Brigham GS. Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. J Subst Abuse Treat 2006;31:25-39.
52.	Kivlighan DM Jr., Kivlighan DM 3^rd. Training related changes in the ways that group trainees structure their knowledge of group counseling leader interventions. Group Dyn 2009;13:190-204.
53.	Miller S, Mee-Lee D, Plum B, Hubble MA. Making treatment count: Client-directed, outcome-informed clinical work with problem drinkers. In: Lebow J, editor. Handbook of Clinical Family Therapy. Hoboken, NJ: John Wiley and Sons; 2005. p. 281-308.
54.	Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008;165:179-87.
55.	Smedslund G, Berg RC, Hammerstrøm KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev 2011;(5):CD008063.
56.	Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2011;(10):CD004147.
57.	DoD. Directive 1010.4: Drug and Alcohol Abuse by DoD Personnel. Washington, DC: DoD; 1997.
58.	GAO (Government Accountability Office). Prescription Drug Control: DEA has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results. Washington, DC: GAO; 2011.
59.	U.S. Army. ALARACT 062/2011: Changes to Length of Authorized Duration of Controlled Substance Prescriptions in MEDCOM Regulation 40-51. Washington, DC: Office of the Army Surgeon General; 2011.
60.	VA, DoD. VA/DoD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain. Washington, DC: VA and DoD; 2010.
61.	Gewirtz AH, Erbes CR, Polusny MA, Forgatch MS, Degarmo DS. Helping military families through the deployment process: Strategies to support parenting. Prof Psychol Res Pr 2011;42:56-62.
62.	Spera C, Barlas F, Szoc RZ, Prabhakaran J, Cambridge MH. Examining the influence of the Enforcing Underage Drinking Laws (EUDL) program on alcohol-related outcomes in five communities surrounding Air Force bases. Addict Behav 2012;37:513-6.
63.	U.S. Army. Army Regulation 600-85: The Army Substance Abuse Program; 2009. Available from: http://www.apd.army.mil/pdffiles/r600_85.pdf. [Last cited on 2016 Aug 11].
64.	U.S. Navy. SECNAVINST 5300.28E: Military Substance Abuse Prevention and Control. Washington, DC: Department of the Navy; 2011.
65.	Doering PL, Boothby LA. Drug testing in the workplace: What the pharmacist should know. Drug Topics Mod Med 2003;147:68-77.
66.	Abadinsky H. Drug use and Abuse: A Comprehensive Introduction. Belmont: Wadsworth Cengage Learning; 2014.
67.	Hawkins EJ, Grossbard J, Benbow J, Nacev V, Kivlahan DR. Evidence-based screening, diagnosis, and treatment of substance use disorders among veterans and military service personnel. Mil Med 2012;177 8 Suppl:29-38.
68.	Runyan CN, Fonseca VP, Hunter C. Integrating consultative behavioral healthcare into the Air Force medical system. In: O'Donohue WT, Ferguson KE, Cummings NA, editors. Behavioral Health as Primary Care: Beyond Efficacy to Effectiveness. Reno, NV: US:2003. p. 145-63.
69.	U.S. Air Force. Instruction 44-121: Alcohol and Drug Abuse Prevention and Treatment (ADAPT) Program. Washington, DC: Department of the Air Force; 2011.
70.	Dale V, Coulton S, Godfrey C, Copello A, Hodgson R, Heather N, et al. Exploring treatment attendance and its relationship to outcome in a randomized controlled trial of treatment for alcohol problems: Secondary analysis of the UK Alcohol Treatment Trial (UKATT). Alcohol Alcohol 2011;46:592-9.
71.	McKay JR. Continuing care research: What we have learned and where we are going. J Subst Abuse Treat 2009;36:131-45.
72.	American Society of Addiction Medicine. ASAM Patient Placement Criteria for the Treatment of Substance Related Disorders. Chevy Chase MD: ASAM, Inc.; 2013.
73.	Fisher GL, Roget NA. Encyclopedia of Substance Abuse Prevention, Treatment, and Recovery. Nevada, Reno: Sage Publications, Inc.; 2009.
74.	Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. New York: Guilford Press; 2002.
75.	Dennis ML, Foss MA, Scott CK. An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Eval Rev 2007;31:585-612.
76.	Carroll KM. Recent advances in the psychotherapy of addictive disorders. Curr Psychiatry Rep 2005;7:329-36.
77.	DCoE (Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury). DCoE Pilot Project Evaluation Report A401: Fort Hood Intensive Outpatient Program (IOP). Arlington, VA: DCoE; 2011.
78.	Imel ZE, Wampold BE, Miller SD, Fleming RR. Distinctions without a difference: Direct comparisons of psychotherapies for alcohol use disorders. Psychol Addict Behav 2008;22:533-43.
79.	Moos RH. Theory-based active ingredients of effective treatments for substance use disorders. Drug Alcohol Depend 2007;88:109-21.
80.	Schuckit MA. Alcohol-related disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9^th ed. New York: Lippincott Williams and Wilkins; 2009. p. 1269-88.
81.	Strain C, Lofwall MR, Jaffe JH. Opioid-related disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9^th ed. New York: Lippincott Williams and Wilkins; 2009. p. 1361-87.
82.	Hughes JR. Nicotine-related disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9^th ed. New York: Lippincott Williams and Wilkins; 2009. p. 1353-60.
83.	Tetrault JM, Fiellin DA. Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals. Drugs 2012;72:217-28.
84.	Humphreys K, Wing S, McCarty D, Chappel J, Gallant L, Haberle B, et al. Self-help organizations for alcohol and drug problems: Toward evidence-based practice and policy. J Subst Abuse Treat 2004;26:151-8.
85.	Petrakis IL, Rosenheck R, Desai R. Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness. Am J Addict 2011;20:185-9.

Advanced Biomedical Research